Skip to content

    Tata Elxsi

    TATAELXSI
    Information Technology·14 Jul 2026
    Management Summary

    Tata Elxsi reported strong Q1 FY27 results, surpassing INR 1,000 crores in quarterly revenue, driven by robust growth in Media & Communication and Transportation verticals. Despite sequential EBIT margin compression due to one-off costs and strategic investments in AI and talent, the company maintains its high-single-digit growth aspirations for FY27, expecting margin recovery in subsequent quarters.

    Highlights

    6
    • Quarterly operating revenue reached INR 1,021.1 crores, surpassing the INR 1,000 crore milestone.

    • Revenue grew 6.5% year-on-year and 1.3% quarter-on-quarter in constant currency.

    • EBITDA increased 15.7% year-on-year to INR 216 crores, with an EBITDA margin of 21.2%.

    • Media and Communication business delivered robust growth of 11.5% YoY in constant currency.

    • Transportation business showed resilient performance with 6.7% YoY growth in constant currency, with 78% from OEM customers.

    • US region performed well across verticals, driven by new deal wins and ramp-ups.

    Concerns

    3
    • Healthcare business was near flat quarter-on-quarter (-0.3% CC) due to delayed deal awards.

    • EBIT margin decreased 330 bps sequentially due to one-off costs and strategic investments.

    • Incurred additional costs for onsite deployment, subcontractors, and provisions related to a customer's Chapter 11 filing.

    Key financials

    Single quarter

    05 metrics
    1. 01Operating Revenue₹1,021.1 Cr+6.5%YoY
    2. 02EBITDA₹216 Cr+15.7%YoY
    3. 03EBITDA Margin21.2%
    4. 04EBIT Margin Change (QoQ)-330 bps
    5. 05EBIT Margin Change (YoY)80 bps

    Segment breakdown

    YoY Growth (CC)YoY Growth (Natural Currency)QoQ Growth (CC)
    Transportation6.7%13.3%
    Media and Communication11.5%22.2%2.9%
    Healthcare-0.3%
    Heatmap· 3 shared metrics

    Order Book

    low confidence

    Pipeline

    deal pipeline tcv

    Deal pipeline based on SDV

    "Management noted strong deal traction and pipeline in US and APAC, with some large deals placed in Europe despite market uncertainty, but did not quantify the order book or new deal wins."

    Source:
    Inferred

    Guidance & targets

    4
    CategoryTargetPriority
    Revenue
    FY27 Revenue Growth (High-Single-Digit)
    High-single-digit
    Medium
    Profitability
    EBIT Margin Recovery
    Profitable quarter
    Medium
    Profitability
    EBIT Margin Sequential Ramp-up
    Sequential ramp-up
    Medium
    Operational Efficiency
    Offshore-Onsite Mix
    75% offshore, 25% onsite
    High

    Healthcare Business Growth

    Next quarter (Q2 FY27) and subsequent quarters
    Current-0.3% QoQ in constant currency
    TargetPositive growth, contributing to high-single-digit FY27 aspiration

    Why it matters

    Healthcare's recovery is explicitly linked to achieving the company's overall FY27 growth aspiration.

    our aspiration continues to be the same. We just need our healthcare business also to fire up, and then I'm sure that we will be able to get to that sort of a growth rate that we are aspiring.

    How to verify

    key_financials.segment_breakdown[name='Healthcare'].metrics[label='QoQ Growth (CC)']

    Risks & concerns

    4
    RiskSeverity

    Delayed deal awards in Healthcare

    The healthcare business exited near flat with a -0.3% quarter-on-quarter in constant currency, reflecting the muted global healthcare business environment. The anticipated momentum was staggered by delayed deal awards from some of our key customers.Management acknowledged

    medium

    Macroeconomic challenges in Continental Europe (Transportation)

    The Europe situation is a little we have to wait and watch, given the challenges in the German market and so on.Management acknowledged

    medium

    Higher provisions due to customer Chapter 11 filing

    Lastly, we had, very recently a Chapter 11 in one of our customers, which sort of led to higher provisions for the quarter, which you'll be able to see in the financials.Management acknowledged

    medium

    Visa delays and reliance on subcontractors for onsite ramp-ups

    We have incurred additional cost of deploying forward teams as well as specialist third-party contractors to help accelerate transitions and mitigate visa delays for our engineers.Management acknowledged

    medium

    Q&A highlights

    8

    “our aspiration continues to be the same. We just need our healthcare business also to fire up, and then I'm sure that we will be able to get to that sort of a growth rate that we are aspiring. So I think we're not changing our aspirations.”

    Confirms the company's commitment to high-single-digit growth despite current challenges in healthcare and some transportation segments, making healthcare recovery a key monitorable.

    asked by Moez Chandani

    2 min read7 chapters

    Detailed Narrative

    01

    Strong Q1 FY27 Revenue Growth Despite Margin Headwinds

    Tata Elxsi achieved quarterly operating revenues of INR 1,021.1 crores in Q1 FY27, marking a 6.5% year-on-year and 1.3% quarter-on-quarter growth in constant currency. EBITDA stood at INR 216 crores, growing 15.7% YoY, with an EBITDA margin of 21.2%. However, sequential EBIT margins saw a 330 bps decline due to one-off📎 costs and strategic investments, though the company maintains its high-single-digit growth aspirations for FY27.

    02

    Vertical Performance Highlights

    Growth was primarily led by Media & Communication, which grew 11.5% YoY in constant currency, and Transportation, which grew 6.7% YoY in constant currency. The transportation segment continues to be a major contributor, accounting for over 55% of SDS segment revenue, with 78% of automotive revenues from OEM customers. The healthcare business, however, remained near flat QoQ at -0.3% in constant currency due to delayed deal awards.

    03

    Strategic Investments and AI Focus

    The company continues to invest in platforms like ViTel and AnaTel, and has accelerated platform-led offerings such as Neuron, which delivered 30-70% efficiencies for clients like Sky in Europe. Strategic investments are focused on specialized talent, AI tools, and infrastructure, aimed at strengthening their 'human plus AI plus domain' proposition. Management views AI as an enabler for productivity and quality, not primarily cost reduction, in mission-critical industries.

    04

    Detailed Breakdown of Margin Compression and Recovery Outlook

    Sequential EBIT margin compression was attributed to three main factors: 40-50 bps from cross-currency gains (positive), ~150 bps from one-off📎 costs (transition, employee retention, customer-specific, upfronted annual costs), and ~220-230 bps from investments (onsite sales/delivery, AI tools, infrastructure). Management expects the 150 bps one-off📎 costs to largely dissipate in Q2, with a sequential margin ramp-up anticipated towards Q4 FY27, partially offset by Q2 wage hikes.

    05

    Offshore-Onsite Mix and Cost Management

    The onsite-offshore ratio shifted by approximately 90 basis points this quarter, reaching 74% offshore and 26% onsite, primarily due to the need for subcontractors for quick ramp-ups on large deals in the US amidst visa delays. Management reiterated its long-term target of 75% offshore/25% onsite and plans to move work back offshore in subsequent quarters, confirming no structural change to its business model.

    06

    Proactive Talent Retention Amidst High Demand

    With attrition at 16%, Tata Elxsi is proactively managing talent, including a company-wide wage revision in Q2, to retain critical AI-ready and domain-specific talent. This strategy aims to prevent talent shortages as revenue growth accelerates, especially given aggressive hiring by GCCs for specialized skills. Fresher hiring is moderated, with only 100-150 engineers added last quarter.

    07

    Geographical Performance and Outlook

    The US region performed well across verticals, driven by new deal wins and ramp-ups. In the transportation vertical, while Continental Europe (over 40% of revenues) faces some softness, strong deal pipelines and conversions in the US (25-30% of revenues) and APAC are expected to offset this, contributing to overall growth in subsequent quarters.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.